Blood Cancer Education: How to Understand Different Diagnosis

0
(0)

There are many different types of blood cancer, which are characterized by an abnormally high amount of white blood cells that cannot fight infections, causing an impairment in the capacities of the bone marrow to produce red blood cells and platelets. Understanding the differences may be difficult, which is why this video, focused on finding education about the topic, may be helpful. Dr. Scott Bearman, MD, from the Colorado Blood Cancer Institute, discusses ways to educating yourself about a specific blood cancer.

After a diagnosis with blood cancer, it is important to talk not only to the primary care physician, but also to a specialist in blood cancer, recommends the physician in the video shared at the Presbyterian/St. Luke’s Medical Center and Rocky Mountain Hospital for Children at P/SL Youtube channel. Dr. Bearman adds that being educated can only be helpful in understanding the disease, the treatment, and the whole process, while seeking information on websites that not certified can be misleading and inaccurate.

The subtypes of blood cancer treated at the Blood Cancer Institute include acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), amyloidosis, aplastic anemia, chronic lymphocytic leukemia (CLL), chronic myeloid leukemia (CML), Hodgkin lymphoma, multiple myeloma, myelodysplastic syndrome (MDS), and non-Hodgkin lymphoma (NHL), which act differently in the body and affect different parts of the body.

Learn more about lymphoma here: http://bit.ly/1UwWKe6

Lymphoma News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
×
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
Latest Posts
  • ATG-019 Phase 1 trial
  • ME-401, FDA fast track
  • Tafasitamab combo, lymphoma
  • blood biomarkers

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *